Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers

Published:2020 Issue:6 Volume:31 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Ha Hyeong In¹^ORCID,Ryu Jin-Sun²^ORCID,Shim Hyoeun³^ORCID,Kong Sun-Young²³^ORCID,Lim Myong Cheol¹⁴⁵^ORCID

Affiliation:

1. Center for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

2. Division of Translational Science, Research Institute, National Cancer Center, Goyang, Korea.

3. Department of Laboratory Medicine, Center for Diagnostic Oncology, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

4. Division of Tumor Immunology, Research Institute, National Cancer Center, Goyang, Korea.

5. Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.

Funder

National Cancer Center

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynaecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2020.31.e83

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management;Cancer Medicine;2024-08

2. Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres;2024-05-28

3. Variant reclassification and clinical implications;Journal of Medical Genetics;2024-01-31

4. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants;Clinical Laboratory;2024

5. Correspondence on ‘Survival outcomes in patients withBRCAmutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors’ by Musacchio et al;International Journal of Gynecologic Cancer;2023-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3